CLINICAL BENEFIT OF NEUROHORMONAL BLOCKADE IN WOMEN WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS AND HEART FAILURE WITH PRESERVED EJECTION FRACTION

被引：0
|
作者：
Kong, Darren [1 ]
Omar, Alaa [1 ]
Pena, Maria K. [1 ]
Kaur, Arpanjeet [1 ]
Correa, Ashish [1 ]
Argulian, Edgar [1 ]
Contreras, Johanna Paola [1 ]
Fox, Arieh L. [1 ]
Mahmood, Kiran [1 ]
机构：
[1] Mt Sinai Morningside West, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1593-174
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [21] Prevalence of transthyretin cardiac amyloidosis in patients hospitalized for heart failure with preserved ejection fraction and septal thickness.
    Decotto, Santiago
    Villar, Gonzalo Fernandez
    Llamedo, Maria Clara
    Villanueva, Eugenia
    De Arenaza, Diego Perez
    Lucas, Luciano
    Del Castillo, Santiago
    Rossi, Emiliano
    Belziti, Cesar
    Pizarro, Rodolfo
    MEDICINA-BUENOS AIRES, 2024, 84 (05) : 823 - 830
  • [22] Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: A contemporary meta-analysis
    Gallo, Giovanna
    Tocci, Giuliano
    Fogacci, Federica
    Battistoni, Allegra
    Rubattu, Speranza
    Volpe, Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 316 : 172 - 179
  • [23] Transthyretin cardiac amyloidosis in heart failure with preserved ejection fraction: Imaging by Tc-99m bone scan
    Fukuzawa, S.
    Okino, S.
    Ishiwaki, H.
    Iwata, Y.
    Uchiyama, T.
    Kuroiwa, N.
    Oka, M.
    Furihata, S.
    Shibayama, N.
    Inagaki, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1676 - 1676
  • [24] Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
    Castiglione, Vincenzo
    Gentile, Francesco
    Ghionzoli, Nicola
    Chiriacao, Martina
    Panichella, Giorgia
    Aimo, Alberto
    Vergaro, Giuseppe
    Giannoni, Alberto
    Passino, Claudio
    Emdin, Michele
    CARDIAC FAILURE REVIEW, 2023, 9
  • [25] Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly
    Tian, Zhuang
    Ren, Chao
    Huo, Li
    Li, Xiao
    Wang, Yi-Ning
    Huang, Lun
    Tian, Ran
    Zhang, Shu-Yang
    JOURNAL OF GERIATRIC CARDIOLOGY, 2020, 17 (12) : 793 - 796
  • [26] Wild-type transthyretin cardiac amyloidosis: An underlying cause of heart failure with preserved ejection fraction (HFpEF) in the elderly
    Brock, A.
    Kerzner, L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S149 - S149
  • [27] Cardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials
    Schelbert, Erik B.
    Miller, Christopher A.
    JACC-HEART FAILURE, 2017, 5 (08) : 617 - 617
  • [28] Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly
    Zhuang TIAN
    Chao REN
    Li HUO
    Xiao LI
    YiNing WANG
    Lun HUANG
    Ran TIAN
    ShuYang ZHANG
    Journal of Geriatric Cardiology, 2020, 17 (12) : 793 - 796
  • [29] Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly
    Zhuang TIAN
    Chao REN
    Li HUO
    Xiao LI
    Yi-Ning WANG
    Lun HUANG
    Ran TIAN
    Shu-Yang ZHANG
    Journal of Geriatric Cardiology, 2020, 17 (12) : 793 - 796
  • [30] Echocardiographic Patterns of Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction
    Rodriguez-Correa, Carlos
    Bonios, Michael J.
    Conte, Jorge
    Taleb, Iosif
    Wilson, Brent D.
    Gilbert, Edward M.
    Stehlik, Josef
    Drakos, Stavros G.
    Fang, James C.
    Nativi-Nicolau, Jose
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S43 - S44
12345